Citius Pharmaceuticals Inc
CTXR1.070USD
+0.050+4.90%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
15.49MMarket Cap
LossP/E TTM
Citius Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-149.35
-2582.35%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -149.346, with a year-on-year change of -2582.35%.
What is the net income of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its net income was -40.19M, with a year-on-year change of -19.27%.
What is the net margin of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -49.95%, with a year-on-year change of -43.54%.
What is the Return on Assets (ROA) of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -35.80%, with a year-on-year change of -19.69%.
What is the operating profit of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -42.00M, with a year-on-year change of -14.33%.
What are the current assets of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its current assets were 14.22M, with a year-on-year change of -58.63%.
What are the total assets of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its total assets of Citius Pharmaceuticals Inc were 116.65M, with a year-on-year change of 12.59%.
What are the total liabilities of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Citius Pharmaceuticals Inc were 42.55M, with a year-on-year change of 249.35%.
What is the total equity of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its total equity of Citius Pharmaceuticals Inc was 74.10M, with a year-on-year change of -18.95%.
What is the net operating income of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Citius Pharmaceuticals Inc was -39.43M, with a year-on-year change of -21.15%.
What is the net investment of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its net investment of Citius Pharmaceuticals Inc was -5.00M, with a year-on-year change of --.
What is the net financing of Citius Pharmaceuticals Inc?
According to Citius Pharmaceuticals Inc's FY2024 earnings report, its net financing of Citius Pharmaceuticals Inc was 9.97M, with a year-on-year change of -27.89%.
